Epidiolex, made by the United Kingdom-based GW Pharmaceuticals for the treatment of epilepsy, will likely become the first cannabis-derived medication approved by the FDA.

A panel of 13 advisers to the FDA unanimously suggested the drug be approved, examining medical trials and gauging the risk-benefit factors to prescribing the medication.

The CBD-based medication will face FDA review in June.

Epidiolex would be the first cannabis-based pharmaceutical to be approved by the FDA. The drug contains no THC, and would not have any psychoactive effects.

There is a consensus that cannabis-based treatments have an immensely positive effect on people struggling with epilepsy, even children. Some studies indicate that CBD oils can cut down on seizures by 50%.

Originally via Herb

Epidiolex, made by the United Kingdom-based GW Pharmaceuticals, might become the first FDA-approved drug for the treatment of epilepsy. Although cannabis has been used anecdotally for years to treat seizures, CBD and THC may finally get the regulatory stamp of approval.

See the full article at https://herb.co/marijuana/news/epidiolex-cannabis-epilepsy